Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $36,633 - $40,675
-575 Reduced 15.11%
3,230 $207 Million
Q4 2022

Jan 31, 2023

BUY
$68.48 - $81.09 $260,566 - $308,547
3,805 New
3,805 $274 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pacific Sage Partners, LLC Portfolio

Follow Pacific Sage Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Sage Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Sage Partners, LLC with notifications on news.